Author
@_marketpartners
grade Cx.com/_marketpartners ↗
Financial advisory/portfolio-management account that posts actively about Nasdaq, $QQQ, $NVDA, $SNDK and other market structure topics. Market-focused but regional/mid-tier rather
trader score
-0.20
hit rate
55%
mean α
-0.36%
signals 14d
6
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 55% hit rate, -0.36% mean alpha, trader score -0.20. Their last-14d mentions, direction-adjusted, have moved -19.9% since posting (mean over 4 mentions with price data).
Recent signals6receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-21 | · | @_marketpartners | · | Warns that AI can fail basic financial calculations and mislead users who do not verify outputs. | · | tweet ↗ |
| 2026-08-19 | MRNA | @_marketpartners | +0.45 | Reports MRNA closing up 178% and describes the move as extraordinary and highly speculative. | -20.9% | tweet ↗ |
| 2026-08-19 | GLOB | @_marketpartners | +0.65 | Says selling pressure is exhausted and projects GLOB toward $48-$50 and its daily 200 EMA. | · | tweet ↗ |
| 2026-08-19 | MRNA | @_marketpartners | +0.55 | Reports a 135% MRNA short squeeze with call prices rising by very large percentages. | -20.9% | tweet ↗ |
| 2026-08-19 | MRNA | @_marketpartners | +0.50 | Reports positive Phase 3 personalized-cancer-vaccine results and a greater-than-100% premarket rise. | -20.9% | tweet ↗ |
| 2026-08-17 | SNDK | @_marketpartners | +0.70 | Recaps SNDK gaining almost 80% since a 200-day EMA technical trigger. | -16.9% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.